StonvexLoading…
StonvexStonvexStonvexCore line items from TR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $732.52M | $723.22M | $769.37M | $686.97M |
Operating Income | $100.94M | $100.50M | $101.83M | $110.75M |
Net Income | $100.05M | $86.83M | $91.91M | $75.94M |
EPS (Diluted) | $1.37 | $1.18 | $1.28 | $1.04 |
Total Assets | $1.25B | $1.15B | $1.08B | $1.02B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $127.17M | $138.84M | $75.92M | $53.27M |
Free Cash Flow OCF − CapEx | $96.35M | $120.89M | $67.81M | $48.70M |
Shares Outstanding | 72.91M | 73.44M | 71.90M | 72.94M |